Mecanismos de señalización celular en enfermedades hepáticas, cardiovasculares y cáncer
Instituto de Investigación Sanitaria del Hospital Clínico San Carlos
Madrid, EspañaPublications in collaboration with researchers from Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (2)
2022
-
Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinoma
Matrix Biology, Vol. 111, pp. 207-225
2021
-
Inhibition of RAC1 activity in cancer associated fibroblasts favours breast tumour development through IL-1β upregulation
Cancer Letters, Vol. 521, pp. 14-28